Tru Niagen is the flagship brand of Niagen Bioscience (formerly ChromaDex), a global leader in NAD+ and healthy aging research with over 25 years of scientific innovation. Powered by Niagen®, the most efficient, safe, and well-researched form of nicotinamide riboside (NR), Tru Niagen is clinically proven to increase and sustain NAD+ levels — supporting cellular energy, resilience, and longevity from the inside out.

Recognized as the number one NAD+ supplement brand in the United States, Tru Niagen sets the gold standard for scientific rigor, quality, and transparency. Its foundation is built on more than 35 human clinical trials, 400+ published scientific studies, and endorsements from two Nobel Prize winners. The company’s patented NR ingredient has been accepted by leading regulatory bodies around the world and is trusted by researchers, healthcare professionals, and consumers seeking evidence-based solutions to optimize aging.

Tru Niagen’s science is led by an internationally renowned advisory board, including Dr. Charles Brenner, the pioneering biochemist who discovered NR’s NAD-boosting potential, and experts from institutions such as Stanford, Harvard, the NIH, and the Scripps Research Institute. Together, they continue to shape the future of healthy aging through collaborative research, global partnerships, and breakthrough discovery.

From its roots in molecular nutrition to its growing presence in markets worldwide, Tru Niagen represents a transformative approach to aging well — energizing lives, supporting cellular health, and helping people get the most out of every moment.